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Previous surveys of the prevalences of genotypes of hepatitis C virus (HCV) in different populations have
often used genotyping assays based upon analysis of amplified sequences from the 5* noncoding region
(5*NCR), such as restriction fragment length polymorphism (RFLP) or hybridization with type-specific probes
(e.g., InnoLipa). Although highly conserved, this region contains several type-specific nucleotide polymor-
phisms that allow major genotypes 1 to 6 to be reliably identified. Recently, however, novel HCV variants found
in Vietnam and Thailand that are distantly related to the type 6a genotype (type 6 group) by phylogenetic
analysis of coding regions of the genome often have sequences in the 5*NCR that are similar or identical to
those of type 1 and could therefore not be identified by any assay of sequences in this region. We developed a
new genotyping assay based upon RFLP of sequences amplified from the more variable core region to
investigate their distribution elsewhere in southeast (SE) Asia. Among 108 samples from blood donors in seven
areas that were identified as type 1 by RFLP in the 5*NCR, type 6 group variants were found in Thailand (7
from 28 samples originally identified as type 1) and Burma (Myanmar) (1 of 3) but were not found in Hong
Kong (n 5 43), Macau (n 5 8), Taiwan (n 5 6), Singapore (n 5 2), or Malaysia (n 5 18). Although this small
survey suggests a relatively limited distribution for type 6 group variants in SE Asia, larger studies will be
required to explore their distribution in other geographical regions and the extent to which their presence
would limit the practical usefulness of 5*NCR-based genotyping assays for clinical or epidemiological pur-
poses.
Hepatitis C virus (HCV) is a positive-stranded RNA virus of
approximately 9,400 nucleotides and has been shown to be the
major etiologic agent of parentally transmitted non-A, non-B
hepatitis (7). Sequence comparisons of variants from different
geographical areas have led to the identification and classifi-
cation of at least six major genotypes, many of which contain a
number of more closely related, yet distinct subtypes of the
virus (5, 20, 24). Phylogenetic analysis of complete genomic
sequences (16) or even relatively short subgenomic regions
(core [6, 15, 24], E1 [5], NS-4 [2, 21], or NS-5 [11]) may be used
for virus classification into genotypes. The overall sequence
similarities over complete genomic sequences are at least 91%
within variants of the same genotype, approximately 79%
(range, 77 to 80%) between subtypes, and about 68% (range,
66 to 69%) between different types (26).
Infection with different genotypes may produce clinically
relevant differences in the liver disease caused by HCV. For
example, there are now several reports describing a greater
sensitivity of HCV genotypes 2 and 3 to interferon treatment
than is found in type 1-infected patients (for recent reviews,
see references 4 and 19). Assays that can identify the infecting
genotype without having to sequence the virus directly are
therefore becoming important in patient management and in
epidemiological studies of HCV transmission. Published geno-
typing methods fall into one of two categories, those based
upon direct virus detection by reverse transcription-PCR, fol-
lowed by analysis of the amplified DNA, or indirect (serolog-
ical) assays, in which the infecting genotype is inferred from
the pattern of antibody reactivity to type-specific epitopes in
the core or NS-4 region (2, 14, 21, 25).
Although the 59 noncoding region (59NCR) of HCV is
highly conserved between genotypes, it is an attractive target
for genotyping assays, because of the strong association of
specific nucleotide polymorphisms with genotype (for a recent
review, see reference 22). These genotypes may be readily
identified by restriction endonucleases or by type-specific
probes (9, 27), although the accuracy for the detection of
genotypes 1 to 6 is limited to 96 and 84% for the two assays,
respectively (22), mainly because of misidentification of more
recently described genotypes.
Recently, several new variants have been identified among
blood donors and hepatitis C patients in Vietnam (26) and
Thailand (1, 15). Sequence comparisons of the core, NS-5, and
E1 regions indicated that these new genotypes often showed
sufficient nucleotide differences from existing variants to be
classified as new major genotypes. However, we have found
that these novel variants group with type 6 upon phylogenetic
analysis in both the E1 and NS-5 regions (15), producing what
may equally well be interpreted as a single, highly diverse
single genotype that includes the previously described type 6a
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genotype found in Hong Kong and Macau (5, 9, 20). These
new variants are referred to as type 6 group variants in this
study.
Although type 6a and all of the previously described major
genotypes (types 2 to 5) show conserved nucleotide differences
from type 1 in the 59NCR that allow them to be differentiated
by restriction endonucleases or by type-specific probes in In-
noLipa, many (but not all) of the novel variants from Vietnam
and Thailand have sequences in the amplified region used for
genotyping that are identical to those of type 1a or 1b. Al-
though mixed infection could lead to the detection of se-
quences of different genotypes in different amplified regions,
this explanation was ruled out by finding continuous clones
that contained type 6 group sequences in the core and E1
regions but a 59NCR sequence similar to that in type 1 in
several samples from Vietnam (26). This finding leads to new
difficulties when interpreting results from genotyping assays
based upon the 59NCR; samples that appear to be type 1 in the
restriction fragment length polymorphism (RFLP) assay (9) or
InnoLipa (9) may instead have been variants within the type 6
phylogenetic group.
The core gene encodes a putative nucleocapsid protein,
which is the most conserved protein in the HCV genome.
Nevertheless, it is considerably more variable than the 59NCR
and contains sufficient sequence information to identify all
known subtypes and major genotypes, including those in the
type 6 group that are misclassified by using the 59NCR (15). To
investigate the distribution of these novel sequences in South-
east (SE) Asia, we have developed a genotyping assay in which
sequences in the core region are amplified and cleaved by
restriction enzymes that reliably differentiate type 1 variants
from type 6 variants. These results provided information on the
distribution of type 6 variants in SE Asia and the frequency
with which conventional genotyping assays produced incorrect
results in different countries.
MATERIALS AND METHODS
Samples. Plasma samples that had been previously genotyped in the 59NCR by
RFLP (9) from blood donors in Macau, Malaysia, Singapore, Taiwan, and Thai-
land were used in the current study. Additional samples from Hong Kong (n 5
66), Malaysia (n 5 8), and Burma (Myanmar) (n 5 8) were also obtained and
genotyped by the same method prior to analysis in the core region. From the
blood donor population in Hong Kong, genotypes 1a (Myanmar) (n 5 3), 1b (n
5 40), 2 (n 5 1), and 6a (n 5 22) were present, similar to the results of our
previous survey (9). From Malaysia, genotypes 1a (n 5 10), 1b (n 5 8), and 3 (n
5 9) were found upon combining the original and new samples. From Burma,
types 1b (n 5 3), 2 (n 5 2), and 3 (n 5 3) were identified.
The survey group in the current study was confined to samples of genotype 1
in the 59NCR RFLP assay that could be amplified in the core region (see below).
From Thailand, it was possible to amplify 28 of the 34 type 1 samples in the core
region. All of the samples from Burma (n 5 3), Hong Kong (n 5 43), and
Malaysia (n 5 18) could be amplified. Lower frequencies of amplification in the
core region were obtained from the survey countries surveyed: Macau, 8 of 13;
Taiwan, 6 of 53; and Singapore, 2 of 5. Although the core primers are similar in
sensitivity to those in the 59NCR, it is likely that storage conditions influenced
the effectiveness of the PCR for the amplification of samples from some coun-
tries. A total of 108 samples from all of the countries were used. Previously
published sequences from Vietnam and Thailand (1, 6, 26), as well as 25 new
core sequences for type 6a (17a), were also included in the analysis.
RNA extraction and nested PCR amplification. Virus RNA was extracted
directly from 100 ml of serum with proteinase K-sarcosyl; this was followed by
phenol-chloroform extraction and precipitation in ethanol as previously de-
scribed (9). RNA was reverse transcribed by using the specific outer antisense
core primer 410. This was followed by the first round of PCR with primers 410
and 954 and a second round with primers 951 and 953, described previously (15),
to give a 405-bp product between positions 221 and 1383; the numbering of
nucleotides is from reference 8. Sequences in the 59NCR between positions2245
and 272 were obtained by using primers 209, 939, 211, and 940 (9). The NS-5
region was amplified by using primers 1204, 1203, 518, 517, and 123, as described
by Mellor et al. (15).
RFLP analysis. Cleavage reactions were performed on the reverse transcrip-
tion-PCR 59NCR product as described previously (9). The restriction enzymes
HpaII and DdeI identified nucleotide sequence differences in the 59NCR be-
tween type 1 variants and some type 6 group variants (see Results). Restriction
endonuclease cleavage of amplified core sequences was carried out by using the
restriction endonucleases AvaI and SmaI. DNA was electrophoresed through a
4% Metaphor agarose gel in 13 TBE (Tris-borate-EDTA) containing 0.5 mg of
ethidium bromide per ml. The combined results of the core and 59NCR RFLP
analyses were used to predict the genotype of HCV within the samples.
Direct sequencing of PCR products. Samples showing restriction patterns
different from those predicted from published sequence data were reamplified by
using biotinylated primers. In order to obtain single-stranded DNA for sequenc-
ing, the biotinylated products were bound onto paramagnetic streptavidin-coated
beads (Dynabeads M280; Dynal) as previously described (12). Dideoxy-termina-
tion sequencing reactions were performed by using the Sequenase sequencing kit
from United States Biochemical Corp. according to the manufacturer’s instruc-
tions, except that reactions were carried out in 10% dimethyl sulfoxide and the
template DNA was heat denatured before primer annealing. Sequences were
read manually from autoradiograms and analyzed by using standard sequence
software.
Phylogenetic analysis. Phylogenetic analysis was carried out by using the
program NEIGHBOR in the PHYLIP package, as previously described (20).
Nucleotide sequence accession numbers. New sequences obtained in this study
have been submitted to GenBank and have been assigned accession numbers
L49473 to L49485, respectively.
RESULTS AND DISCUSSION
Development of core RFLP assay. Published nucleotide se-
quences in the core region of types 1 and 6 and novel variants
that grouped with type 6 upon phylogenetic analysis were an-
alyzed with DNAnalyz software to identify restriction enzymes
that recognized sequence polymorphism between HCV geno-
types. Cleavage with AvaI and SmaI consistently showed dis-
tinct predicted restriction patterns for type 1 and non-type 1
sequences (Fig. 1; Table 1). From the total of 13 different
restriction patterns obtained using AvaI (a1 to a13 [Fig. 1A])
and the five patterns obtained using SmaI (s1 to s5 [Fig. 1B]),
published sequences of the type 6 group produced a total of
three combinations of patterns.
FIG. 1. Restriction endonuclease cleavage patterns of amplified core se-
quences using enzymes AvaI (A) and SmaI (B) for published variants and
samples analyzed in the current study. The numbers are the sizes (in base pairs)
of the DNA fragments produced.
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Among published sequences, the most common restriction
pattern for type 1a sequences was a1s1 (n 5 14), while the
majority of type 1b sequences showed the a3s1 pattern (n 5
43) (Table 1). With the exception of three sequences (VN540,
VN787, and VN507), all variants in the type 6 group (includ-
ing type 6a) could be predicted to produce the a12s5 pattern
upon cleavage with AvaI and SmaI (Table 1). In every case,
RFLP patterns distinct from those of type 1 variants were
obtained.
Geographical distribution of surveyed samples. To investi-
gate the distribution of type 6 group variants in SE Asia, a total
of 108 samples from Malaysia, Thailand, Macau, Hong Kong,
Singapore, Burma, and Taiwan that had been previously iden-
tified as type 1 (9) were retested in the new core RFLP assay
(Table 2). A much wider range of restriction patterns than was
obtained from our analysis of published sequences was ob-
tained from this survey. Although the vast majority of samples
produced RFLP pattern a1s1 or a3s1 and could therefore be
identified as type 1a or 1b, the remaining 26 samples produced
a total of 11 distinct RFLP patterns with the two enzymes,
many of which corresponded to those previously associated
with type 6 group variants (Table 1).
Each of the 26 samples was sequenced in the core region to
make a definitive identification of the genotype. Of the 26
samples, 18 could be classified as type 1, while the remaining
8 contained sequences in the core region that placed them
within the type 6 group (see below). These type 6 group se-
quences were found in samples from Thailand (n 5 7) or
Burma (n 5 1) and showed the restriction pattern a11s5 or
a12s5 (Table 2).
Phylogenetic analysis of novel genotypes. To demonstrate
the relationship between the eight type 6 group variants with
those previously found in Vietnam and Thailand, we carried
out phylogenetic analysis of sequences from the core and NS-5
regions of these variants (Fig. 2 and 3). All eight core se-
quences grouped with the type 6 clade and showed various
relationships with variants previously found in Vietnam and
Thailand (13, 15) (Fig. 2). Three samples from Thailand
(EUTH5230, EUTH7, and EUTH13) grouped closely with
variants previously found in Thailand and provisionally classi-
fied as NGII (15). The sample from Burma was closest to but
distinct from variants in Thailand referred to as NGI, while the
remaining four samples (EUTH1, EUTH21, EUTH22, and
EUTH39) showed a distant relationship to variants from Viet-
nam described as type 9a (13).
To investigate further the relationship of the new variants to
those previously found in SE Asia, we compared sequences in
the more variable NS-5 region (Fig. 3). Each new sequence
clustered within the type 6 group, although the addition of the
new sequences from Thailand increased still further the diver-
sity within the group as a whole. Sequence relationships found
in the core region among members of the type 6 group were
closely reproduced in the NS-5 region. For example, the NS-5
sequences of EUTH1 and EUTH22 were distinct from all
previously analyzed variants in the type 6 group but were
closest to VN004 and VN085 from Vietnam, which were de-
scribed as type 9a (13). Similarly, the close relationship be-
tween EUTH5230, EUTH7, and EUTH13 with NGII in the
core region was also found in NS-5. The NS-5 sequence of the
sample from Burma (EUBUR1) was found to be the same
genotype as variants B4-92 and PC found in northern Thailand
(1).
Identification of type 6 group sequences in the 5*NCR. All
published type 6a sequences in the 59NCR are distinct from
type 1 sequences, because they contain characteristic insertions
(CA at position 2146 and C at position 2138) which are
generally not present in other genotypes (22). However, other
variants in the type 6 group show a range of different 59NCR
sequences, none of which contain the CA insertion at position
2146 and which infrequently show the C insertion at position
TABLE 1. Association of different HCV genotypes with RFLP patterns in the core region
Genotype
No. of samples with restriction patterna: Total no. of
samplesa1s1 a2s1 a3s1 a4s1 a4s5 a5s1 a6s5 a7s4 a8s3 a9s2 a10s1 a11s5 a12s5 a13s5
1a 14 2 16
1b 43 5 48
6a 30 30
T6Gb 2 15 1 18
Total no. of samples 14 2 43 5 2 45 1 112
a Combination of restriction patterns as defined in Fig. 1; a1s1 corresponds to pattern 1 with AvaI and pattern 1 with SmaI.
b Variants of HCV within the type 6 clade but excluding the previously classified type 6a genotype.
TABLE 2. Distribution of different core RFLP patterns in the places surveyed
Place
No. of samples with restriction patterna: Total no. of
samplesa1s1 a2s1 a3s1 a4s1 a4s5 a5s1 a6s5 a7s4 a8s3 a9s2 a10s1 a11s5 a12s5 a13s5
Burma 2 1 3
Thailand 9 9 1 1 1 4 3 28
Malaysia 9 1 5 2 1 18
Singapore 1 1 2
Hong Kong 3 38 1 1 43
Macau 1 2 1 1 1 2 8
Taiwan 3 1 2 6
Total no. of samples 22 1 60 3 2 2 2 2 1 1 4 4 4 0 108
a Combination of restriction patterns as defined in Fig. 1; a1s1 corresponds to pattern 1 with AvaI and pattern 1 with SmaI.
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2138. Furthermore, few nucleotide differences are found be-
tween these variants and type 1. In the extreme case, for
VN540, VN843, VN235, VN507, VN530, and VN531, the
59NCR sequences were identical to those of type 1b and the
59NCR sequence of VN085 was identical to that of type 1a
(Fig. 4). On the other hand, most of the variants from Thailand
showed 59NCR sequences that differed at several sites from
type 1 sequences; in the case of sequences previously described
as NGI (15), a conserved pair of covariant changes in the
proposed stem-loop region 3 (3) that could be identified by
cleavage with HpaII (which recognizes the CCGG sequences
present in type 1 sequences but which is disrupted by the
substitution of A for C at position2155 in NGI sequences) was
found. Cleavage of 59NCR sequences using the combination of
DdeI and HpaII from NGI produced pattern B (Fig. 5), clearly
distinguishable from pattern A found in all type 1 59NCR
sequences analyzed to date. A different covariant change in the
same stem-loop structure was found among the sequences de-
scribed as NGII. In this case, cleavage with DdeI identified the
polymorphism at position 2127 (G for A in NGII) and pro-
duced pattern C with the DdeI-HpaII enzyme combination
(Fig. 5). Although pattern D (produced by type 6a 59NCR
sequences [22]) is different from pattern A for type 1, the 3-
base size difference of the large fragment (127 and 130 bp)
would not necessarily be identifiable by agarose gel electro-
phoresis of the cleaved DNA (9).
With this limited ability to identify at least a proportion of
type 6 group variants, we used the DdeI-HpaII enzyme com-
bination to cleave amplified 59NCR sequences from the survey
population. All 100 sequences that were classified as type 1 by
RFLP or sequence analysis of the core region produced pat-
tern A. Among the 8 samples identified in this study as be-
longing to the type 6 group, EUBURI produced pattern B,
while EUTH5230, EUTH7, and EUTH13 produced pattern C.
EUTH1, EUTH21, EUTH22, and EUTH39, which were not
closely related to any of the variants within the type 6 group,
produced pattern A (and had sequences in the 59NCR similar
or identical to type 1b [data not shown]). From this analysis it
can be seen that only half of the type 6 group variants would
have been identified even when using new enzymes designed to
detect observed sequence differences between NGI and NGII
with type 1 sequences.
HCV genotype distribution in SE Asia. The identification of
only eight samples in the type 6 group of HCV genotypes
indicates an extremely limited distribution of these variants in
most of the places surveyed. Seven of these variants were
found in Thailand, consistent with previous observations that
they represent one of the principal variants (with type 3) in
blood donor and hepatitis C patient populations (1, 15). Type
6 group variants (including type 6a) are well documented in
Vietnam (26), and the finding of a single example of this geno-
type in Burma hints at a wider westward distribution in SE
Asia.
In attempts to review current information from other groups
FIG. 2. Phylogenetic analysis of core sequences from the type 6 clade includ-
ing those of eight variants identified in the current group. The phylogenetic tree
was rooted by using sequences from HCV-PT (type 1a [8]) and NZLI (type 3a
[18]) as outgroups. Previously published provisional genotype assignments are
indicated.
FIG. 3. Phylogenetic analysis of NS-5 sequences from the type 6 clade in-
cluding those of eight variants identified in the current group. The phylogenetic
tree was rooted by using sequences from HCV-PT (type 1a [8]) and NZLI (type
3a [18]) as outgroups. Previously published provisional genotype assignments are
indicated.
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on the distribution of HCV genotypes in SE Asia, most data
obtained from genotyping assays such as the RFLP assays (9),
InnoLipa (23), and assays using type-specific primers in the
core region (17) cannot be relied upon because of the limited
range of HCV variants that can be identified. In the current
study, we have shown that type 6 group variants may appear as
type 1 in an RFLP assay based upon the 59NCR, whether or
not it is modified by the use of additional restriction enzymes
such as DdeI and HpaI. In this respect, the survey recently
published by Greene et al. (10) is particularly informative,
because genotype assignments were made by nucleotide se-
quence determinations of several regions of the HCV genome.
The absence of type 6 group variants from a total of 45 samples
collected from Singapore, Indonesia, Philippines, and South
Korea is consistent with the finding in this study of a restricted
distribution of type 6 group variants in Malaysia, Singapore,
Taiwan, Macau, and Hong Kong. However, the survey by
Greene et al. (10) failed to detect type 6 group variants in
Thailand (3 type 1a, 8 type 1b, and 10 type 3a and 3b variants)
and appears inconsistent with their frequent detection in this
study and previous studies (1, 15). It is possible that the fre-
quency of infection with type 6 group variants differs between
geographical regions within Thailand, or it is possible that
there are differences in its distribution in different risk groups
for infection or age of subjects.
Figure 6 attempts to summarize current knowledge of gen-
otype distributions of HCV throughout SE Asia and the Far
East using information obtained from this study and previously
published information (9, 10, 26). The pie charts represent the
relative frequencies of genotypes 1 to 6 as determined by
sequence comparisons in coding regions (9, 15, 26), RFLP
analysis in the 59NCR (9), and genotyping using type-specific
primers in the core region (26). Figure 6 includes a separate
representation of type 6 group variants (indicated as NG, dis-
tinct from type 6a) in the three countries where it has been
detected so far (Vietnam, Thailand, and Burma).
Although the number of samples from some places was
small, this combined analysis reveals some clear geographical
trends in relative genotype frequencies. Type 1b variants ap-
pear ubiquitous throughout the region, and a steady increase in
the frequency of type 3 infection in more westward countries is
apparent, which is not found in the Far East. Type 6 group
variants were found in a single, possibly continuous block that
includes Vietnam, Thailand, and Burma but were not detected
elsewhere. The distribution of type 6 group variants overlaps in
Vietnam with type 6a, with the latter also being prevalent in
Hong Kong and Macau.
Little is currently understood concerning the past epidemi-
ology of HCV transmission that is responsible for the current
distribution of HCV variants. However, the information ob-
tained in this study will be of future use in the understand-
ing of HCV sequence variation and the ancestry of the cur-
rently identified HCV genotypes. In particular, the overlapping
ranges of type 6a with other variants in the type 6 clade in the
mainland of SE Asia provides an insight into their interrela-
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FIG. 5. DNA fragments produced upon cleavage of amplified 59NCR se-
quences from type 1 and type 6 groups using restriction endonucleases DdeI and
HpaII. The numbers are the sizes (in base pairs) of the DNA fragments pro-
duced.
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tionship that will be of value in future evolutionary analyses of
these sequences.
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